Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: Leuk Res. 2017 May 30;60:11–17. doi: 10.1016/j.leukres.2017.05.002

Fig. 2.

Fig. 2.

Momelotinib plasma concentration over time by dose.

ET, essential thrombocythemia; PV, polycythemia vera; Q1, first quartile; Q3, third quartile.